Literature DB >> 25414428

Fluid-dynamic results of in vitro comparison of four pericardial bioprostheses implanted in small porcine aortic roots.

Giordano Tasca1, Riccardo Vismara2, Gianfranco Beniamino Fiore2, Andrea Mangini3, Claudia Romagnoni3, Stefano Pelenghi4, Carlo Antona5, Alberto Redaelli2, Amando Gamba6.   

Abstract

OBJECTIVES: Small-sized aortic bioprostheses may cause high postoperative gradients. In clinical practice, it is difficult to compare bioprostheses from different manufactures, owing to the discrepancy between the true size and the nominal size of the prosthesis and the inter-patient variability in aortic root characteristics. In vitro studies provide accurate data, and using a system in which it is possible to implant bioprostheses in a true aortic root should enable a fair comparison to be made. The present study compared the four most widely used pericardial stented bioprostheses from different manufacturers surgically implanted in small annulus, to detect any differences in their fluid-dynamic performance.
METHODS: The four types of bioprostheses, each implanted in a randomized sequence in eight porcine aortic roots, with a native annulus of 2.1 cm, were tested in a mock loop at 65 ml of stroke volume by calculating hydrodynamic parameters, namely mean pressure drop and effective orifice area, performance index, valve resistance and % of energy loss. The prostheses that fitted the aortic root after sizing were as follows: a Magna Ease 21, a Trifecta 21, a Soprano-Armonia 20 and a Mitroflow 23.
RESULTS: Effective orifice areas were 1.57 ± 0.2, 1.77 ± 0.2, 2.3 ± 0.3 and 1.75 ± 0.2 cm(2) (P < 0.001) for Magna Ease, Mitroflow, Trifecta and Soprano-Armonia, respectively. The mean gradients were 13.2 ± 3, 10.2 ± 3, 6.1 ± 2 and 9.6 ± 2 mmHg (P < 0.001) for Magna Ease, Mitroflow, Trifecta and Soprano-Armonia, respectively. The performance indices were 0.50 ± 0.06, 0.63 ± 0.08, 0.89 ± 0.13 and 0.56 ± 0.07 (P < 0.001) for Magna Ease, Mitroflow, Trifecta and Soprano-Armonia, respectively. The valve resistance, expressed in (dyn*s/cm(5)), was 69 ± 16, 55 ± 13, 33 ± 10 and 51 ± 11 (P < 0.001) for Magna Ease, Mitroflow, Trifecta and Soprano-Armonia, respectively. The percent of energy loss was 13.5 ± 0.5, 10.7 ± 2.5, 6.6 ± 1.6, 10.9 ± 1.8 (P < 0.001) for Magna Ease, Mitroflow, Trifecta and Soprano-Armonia, respectively.
CONCLUSION: Our study combined the fluid-dynamic reproducibility of the in vitro study with, by using porcine aortic roots, the specificity of surgery. The results confirmed that bioprostheses are inherently obstructive compared with the native aortic valve and showed that bioprostheses with the pericardium outside the stent are more efficient.
© The Author 2014. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Adult; Aortic valve replacement; Prosthesis

Mesh:

Year:  2014        PMID: 25414428     DOI: 10.1093/ejcts/ezu446

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

1.  Opening-closing pattern of four pericardial prostheses: results from an in vitro study of leaflet kinematics.

Authors:  Giordano Tasca; Gianfranco Beniamino Fiore; Andrea Mangini; Claudia Romagnoni; Amando Gamba; Alberto Redaelli; Carlo Antona; Riccardo Vismara
Journal:  J Artif Organs       Date:  2016-05-26       Impact factor: 1.731

2.  Anatomical and functional changes after aortic valve replacement with different sizes of mechanical valves.

Authors:  Gokhan Ilhan; Sahin Bozok; Berkan Ozpak; Hakan Kara; Serkan Yazman; Serdar Bayrak; Ibrahim Ozsoyler; Ali Gurbuz
Journal:  Cardiovasc J Afr       Date:  2018-07-17       Impact factor: 0.802

3.  The Prognostic Significance of Patient-Prosthesis Mismatch after Aortic Valve Replacement.

Authors:  Paolo Nardi; Marco Russo; Guglielmo Saitto; Giovanni Ruvolo
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2018-06-05

4.  Structural valve deterioration after aortic valve replacement with the Trifecta valve.

Authors:  Paul Werner; Jasmin Gritsch; Sabine Scherzer; Christoph Gross; Marco Russo; Iuliana Coti; Alfred Kocher; Guenther Laufer; Martin Andreas
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-01-01

5.  St. Jude Medical Trifecta aortic valve: results from a prospective regional multicentre registry.

Authors:  Giovanni Mariscalco; Silvia Mariani; Samuele Bichi; Andrea Biondi; Andrea Blasio; Paolo Borsani; Fabrizio Corti; Benedetta De Chiara; Riccardo Gherli; Cristian Leva; Claudio Francesco Russo; Giordano Tasca; Paolo Vanelli; Ottavio Alfieri; Carlo Antona; Germano Di Credico; Giampiero Esposito; Amando Gamba; Luigi Martinelli; Lorenzo Menicanti; Giovanni Paolini; Cesare Beghi
Journal:  J Cardiothorac Surg       Date:  2015-11-20       Impact factor: 1.637

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.